APA (7th ed.) Citation

CH, C., KC, H., MM, H., HJ, T., SL, P., & MW, C. (2025). Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer. Journal of enzyme inhibition and medicinal chemistry, 40(1), 2538673. https://doi.org/10.1080/14756366.2025.2538673

Chicago Style (17th ed.) Citation

CH, Chung, Hsu KC, Huang MM, Tu HJ, Pan SL, and Chao MW. "Discovery of a Novel RSK2 Inhibitor for the Treatment of Metastatic Pancreatic Cancer." Journal of Enzyme Inhibition and Medicinal Chemistry 40, no. 1 (2025): 2538673. https://doi.org/10.1080/14756366.2025.2538673.

MLA (9th ed.) Citation

CH, Chung, et al. "Discovery of a Novel RSK2 Inhibitor for the Treatment of Metastatic Pancreatic Cancer." Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 40, no. 1, 2025, p. 2538673, https://doi.org/10.1080/14756366.2025.2538673.